|
Volumn 24, Issue 10, 2002, Pages
|
Translating the latest scientific advances into clinical practice.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONJUGATED ESTROGEN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
MEDROXYPROGESTERONE ACETATE;
BREAST TUMOR;
CEREBROVASCULAR ACCIDENT;
CLINICAL PRACTICE;
CORONARY ARTERY DISEASE;
DRUG COMBINATION;
DRUG EFFECT;
EDITORIAL;
ESTROGEN THERAPY;
EVIDENCE BASED MEDICINE;
FEMALE;
GYNECOLOGY;
HUMAN;
MASS COMMUNICATION;
MENOPAUSE;
MIDDLE AGED;
PATIENT SELECTION;
RISK FACTOR;
STANDARD;
TIME;
BREAST NEOPLASMS;
CEREBROVASCULAR ACCIDENT;
CORONARY DISEASE;
DIFFUSION OF INNOVATION;
DRUG COMBINATIONS;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS, CONJUGATED (USP);
EVIDENCE-BASED MEDICINE;
FEMALE;
GYNECOLOGY;
HUMANS;
MEDROXYPROGESTERONE 17-ACETATE;
MENOPAUSE;
MIDDLE AGED;
PATIENT SELECTION;
PHYSICIAN'S PRACTICE PATTERNS;
RISK FACTORS;
TIME FACTORS;
MLCS;
MLOWN;
|
EID: 0036779911
PISSN: 17012163
EISSN: None
Source Type: Journal
DOI: 10.1016/s1701-2163(16)30467-4 Document Type: Editorial |
Times cited : (2)
|
References (0)
|